论文部分内容阅读
本文作者于1980～1987年间采用一种新的姑息治疗方案(放疗、肿瘤切除加放射性核素疗法)治疗直肠中段、下段腺癌25例(男10例,女15例,平均年龄74岁),其中因高龄或对腹会阴切除术、前方切除术有禁忌者14例(平均79岁),拒作结肠造口术者11例(平均62岁);癌肿位于直肠下段者16例(64%),中段者8例,上段1例(距肛缘12 cm,患者年龄82岁,不能耐受前方切除术)。癌肿直径平均为5 cm,3例<3 cm;20例(80%)为增殖型或息肉样癌;高、中、低分化腺癌分别为11例(44%)、7例和6例,另1例为胶样腺癌;癌肿均可移动,钡灌肠和内镜检查均未发现淋巴结肿大。
The authors used a new palliative treatment program (radiotherapy, tumor resection and radionuclide therapy) in the treatment of 25 cases of rectal cancer in the middle and lower segments from 1980 to 1987 (10 males and 15 females, with a mean age of 74 years). Among them, 14 cases (mean age 79 years) were contraindicated due to advanced age or abdominal perineal resection and front resection, and 11 cases (mean 62 years old) were rejected as colostomy; 16 cases were cancer in the lower rectum (64%). ), 8 cases in the middle segment, 1 case in the upper segment (12 cm from the anal verge, the patient was 82 years old and could not tolerate anterior resection). The average diameter of cancer was 5 cm, 3 cases <3 cm; 20 cases (80%) were proliferative or polypoid carcinoma; high, moderate and poorly differentiated adenocarcinomas were 11 cases (44%), 7 and 6 cases respectively. The other case was a colloid adenocarcinoma; all cancers could be moved. No lymphadenopathy was found in barium enema and endoscopy.